Clinical Curaitve Effect of Moxifloxacin in Treatment of Pneumonia
Objective To discuss ultimate effect of moxifloxacin drug treatment after pneumonia outbreak.Methods The paper chose 100 patients diagnosed with pneumonia from October 2020 to October 2022 for statistical analysis,and divided them into two groups based on computer randomization,including control group and experimental group.During treatment,control group was treated with levofloxacin and experimental group with moxifloxacin,50 cases in each group.After 7 days of continuous treatment,the improvement of disease symptoms,lung function indexes and the total treatment effective rate of the two groups were compared.Results ① The time of cough relief,temperature return to normal and lung rales disappearance in the experimental group were shorter than those in the control group(P<0.05);② The pulmonary function indexes(FVC,FEV1,FEV1/FVC)of the experimental group were higher than those of the control group(P<0.05);③ The total effective rate of experimental group was higher than that of control group(P<0.05).Conclusion Moxifloxacin has significant therapeutic advantages in the treatment of patients with pneumonia.After clinical verification,the drug can reduce the disease symptoms of patients and improve the overall treatment efficiency.At the same time,moxifloxacin also performed well in improving lung function indicators,which provided strong support for its wide application in the medical field,demonstrating its high safety and promotion value.
Pneumonia patientsPulmonary function indexTotal effective rateMoxifloxacinLevofloxacin
NETL
NSTL
万方数据
